{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:19:22Z","timestamp":1762100362867},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T00:00:00Z","timestamp":1113782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T00:00:00Z","timestamp":1113782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1038\/sj.bmt.1704943","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T09:14:12Z","timestamp":1113815652000},"page":"1155-1164","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"35","author":[{"given":"A R","family":"Kallianpur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L D","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D W","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Speroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R S","family":"Dittus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Haines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B W","family":"Christman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M L","family":"Summar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,18]]},"reference":[{"key":"BF1704943_CR1","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood.V92.11.4047","volume":"92","author":"SJ Lee","year":"1998","unstructured":"Lee SJ, Anasetti C, Kuntz KM et al. The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood 1998; 92: 4047\u20134052.","journal-title":"Blood"},{"key":"BF1704943_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0889-8588(05)70106-4","volume":"13","author":"L Popplewell","year":"1999","unstructured":"Popplewell L, Forman SJ . Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia, and myelodysplasia. Hematol Oncol Clin North Am 1999; 13: 987\u20131015.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF1704943_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF02982018","volume":"75","author":"GE Georges","year":"2002","unstructured":"Georges GE, Storb R . Stem cell transplantation for aplastic anemia. Int J Hematol 2002; 75: 141\u2013146.","journal-title":"Int J Hematol"},{"key":"BF1704943_CR4","first-page":"2","volume":"85","author":"E Barth","year":"2000","unstructured":"Barth E, Malorgio C, Tamaro P . Allogeneic bone marrow transplantation in hematologic disorders of childhood: new trends and controversies. Haematologica 2000; 85: 2\u20138.","journal-title":"Haematologica"},{"key":"BF1704943_CR5","volume-title":"Wintrobe's Clinical Hematology","author":"AR Kallianpur","year":"1999","unstructured":"Kallianpur AR . Supportive care in the hematological malignancies. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP and Rodgers GM (eds). Wintrobe's Clinical Hematology, 10th edn. Williams and Wilkins, Baltmore, Maryland, 1999."},{"key":"BF1704943_CR6","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"11","author":"SI Bearman","year":"1995","unstructured":"Bearman SI . The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 11: 3005\u20133020.","journal-title":"Blood"},{"key":"BF1704943_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4065\/78.5.589","volume":"78","author":"S Kumar","year":"2003","unstructured":"Kumar S, DeLeve LD, Kamath PS, Tefferi A . Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003; 78: 589\u2013598.","journal-title":"Mayo Clin Proc"},{"key":"BF1704943_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation; a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BF1704943_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.bmt.1704591","volume":"34","author":"AM Evens","year":"2004","unstructured":"Evens AM, Mehta J, Gordon LI . Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 2004; 34: 561\u2013571.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1704716","volume":"35","author":"AR Kallianpur","year":"2005","unstructured":"Kallianpur AR . Genomic screening and complications of hematopoietic stem cell transplantation: has the time come? Bone Marrow Transplant 2005; 35: 1\u201316.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/sj.bmt.1701225","volume":"21","author":"G Matute-Bello","year":"1998","unstructured":"Matute-Bello G, McDonald GB, Hinds MS et al. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. Bone Marrow Transplant 1998; 21: 1125\u20131130.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1001\/archinte.162.14.1558","volume":"162","author":"IA Tabbara","year":"2002","unstructured":"Tabbara IA, Zimmerman K, Morgan C, Nahleh Z . Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 2002; 162: 1558\u20131566.","journal-title":"Arch Intern Med"},{"key":"BF1704943_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.2002.03973.x","volume":"119","author":"MR Litzow","year":"2002","unstructured":"Litzow MR, Perez WS, Klein JP et al. Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan\u2013cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. Br J Haematol 2002; 119: 1115\u20131124.","journal-title":"Br J Haematol"},{"key":"BF1704943_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/107327480301000104","volume":"10","author":"B Djulbegovic","year":"2003","unstructured":"Djulbegovic B, Seidenfeld J, Bonnell C, Kumar A . Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review. Cancer Control 2003; 10: 17\u201341.","journal-title":"Cancer Control"},{"key":"BF1704943_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD De Leve","year":"2002","unstructured":"De Leve LD . Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27\u201342.","journal-title":"Semin Liver Dis"},{"key":"BF1704943_CR16","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slatter JT, Bouvier ME et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043\u20132048.","journal-title":"Blood"},{"key":"BF1704943_CR17","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0891-5849(01)00689-X","volume":"31","author":"K Umegaki","year":"2001","unstructured":"Umegaki K, Sugisawa A, Shin SJ et al. Different onsets of oxidative damage to DNA and lipids in bone marrow and liver in rats given total body irradiation. Free Rad Biol Med 2001; 31: 1066\u20131074.","journal-title":"Free Rad Biol Med"},{"issue":"Suppl. 1","key":"BF1704943_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0168-8278(98)80368-1","volume":"28","author":"A Pietrangelo","year":"1998","unstructured":"Pietrangelo A . Iron, oxidative stress and liver fibrogenesis. J Hepatol 1998; 28 (Suppl. 1): 8\u201313.","journal-title":"J Hepatol"},{"key":"BF1704943_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1089-3261(05)70116-1","volume":"4","author":"HL Bonkovsky","year":"2000","unstructured":"Bonkovsky HL, Lambrecht RW . Iron-induced liver injury. Clin Liver Dis 2000; 4: 409\u2013429, vi\u2013vii.","journal-title":"Clin Liver Dis"},{"key":"BF1704943_CR20","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198558927.001.0001","volume-title":"Free Radicals and Iron: Chemistry, Biology, and Medicine","author":"MCR Symons","year":"1998","unstructured":"Symons MCR, Gutteridge JMC . Free Radicals and Iron: Chemistry, Biology, and Medicine. Oxford University Press, Inc., New York, 1998."},{"key":"BF1704943_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ng0896-399","volume":"13","author":"JN Feder","year":"1996","unstructured":"Feder JN, Gnirke A, Thomas W et al. A novel MHC class-1 like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399\u2013408.","journal-title":"Nat Genet"},{"key":"BF1704943_CR22","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","volume":"341","author":"NC Andrews","year":"1999","unstructured":"Andrews NC . Disorders of iron metabolism. N Engl J Med 1999; 341: 1986\u20131995.","journal-title":"N Engl J Med"},{"key":"BF1704943_CR23","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/gast.2001.29617","volume":"121","author":"S Parkkila","year":"2001","unstructured":"Parkkila S, Niemela O, Britton RS et al. Molecular aspects of iron absorption and HFE expression. Gastroenterology 2001; 121: 1489\u20131496.","journal-title":"Gastroenterology"},{"key":"BF1704943_CR24","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1073\/pnas.082112299","volume":"99","author":"D Trinder","year":"2002","unstructured":"Trinder D, Olynyk JK, Sly WS, Morgan EH . Iron uptake from plasma transferring by the duodenum is impaired in the HFE knockout mouse. Proc Natl Acad Sci USA 2002; 99: 5622\u20135626.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1704943_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/21548331.1999.11443891","volume":"34","author":"RD Press","year":"1999","unstructured":"Press RD . Hemochromatosis: a \u2018simple\u2019 genetic trait. Hosp Pract 1999; 34: 55\u201358, 61, 62, 68.","journal-title":"Hosp Pract"},{"key":"BF1704943_CR26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0168-8278(01)00304-X","volume":"36","author":"DF Wallace","year":"2002","unstructured":"Wallace DF, Walker AP, Pietrangelo A et al. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. J Hepatol 2002; 36: 474\u2013479.","journal-title":"J Hepatol"},{"key":"BF1704943_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1365-2362.2000.00628.x","volume":"30","author":"B de Valk","year":"2000","unstructured":"de Valk B, Addicks MA, Gosriwatana I et al. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000; 30: 248\u2013251.","journal-title":"Eur J Clin Invest"},{"key":"BF1704943_CR28","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJM199612123352403","volume":"335","author":"ZJ Bulaj","year":"1996","unstructured":"Bulaj ZJ, Griffen LM, Jorde LB et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799\u20131805.","journal-title":"N Engl J Med"},{"key":"BF1704943_CR29","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada S, Higgs A . The L\u2013arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002\u20132012.","journal-title":"N Engl J Med"},{"key":"BF1704943_CR30","doi-asserted-by":"publisher","first-page":"12214","DOI":"10.1073\/pnas.192316099","volume":"99","author":"S Kim","year":"2002","unstructured":"Kim S, Ponka P . Nitrogen monoxide-mediated control of ferritin synthesis: implications for macrophage iron homeostasis. Proc Natl Acad Sci USA 2002; 99: 12214\u201312219.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1704943_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1020788603046","volume":"16","author":"S Kim","year":"2003","unstructured":"Kim S, Ponka P . Role of nitric oxide in cellular iron metabolism. Biometals 2003; 16: 125\u2013135.","journal-title":"Biometals"},{"key":"BF1704943_CR32","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1056\/NEJM200106143442404","volume":"344","author":"DL Pearson","year":"2001","unstructured":"Pearson DL, Dawling S, Walsh WF et al. Neonatal pulmonary hypertension. Urea cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med 2001; 344: 1832\u20131838.","journal-title":"N Engl J Med"},{"key":"BF1704943_CR33","unstructured":"Summar ML, Scott N, Cummings E et al. Analysis of 200 patients undergoing bone marrow transplant shows allelic disequilibrium between drug-related toxicity and a common exonic polymorphism in the CPS1 gene and correlates with disruption of urea cycle intermediates. Am J Hum Genet 1999; 65 (Suppl.) (Abstr. 25)."},{"key":"BF1704943_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0378-1119(03)00528-6","volume":"311","author":"ML Summar","year":"2003","unstructured":"Summar ML, Hall LD, Eeds AM et al. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene. Gene 2003; 311: 51\u201357.","journal-title":"Gene"},{"key":"BF1704943_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0140-6736(98)01350-6","volume":"352","author":"S Rodenhuis","year":"1998","unstructured":"Rodenhuis S, Richel D, van der Wall E et al. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement. Lancet 1998; 352: 515\u2013521.","journal-title":"Lancet"},{"key":"BF1704943_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.bmt.1701556","volume":"23","author":"RS Stein","year":"1999","unstructured":"Stein RS, Greer JP, Goodman S et al. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant 1999; 23: 227\u2013233.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR37","first-page":"401","volume":"15","author":"A Leelasiri","year":"1995","unstructured":"Leelasiri A, Greer JP, Stein RS et al. Graft-versus host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine\u2013methotrexate and cyclosporine\u2013methotrexate-methylprednisolone. Bone Marrow Transplant 1995; 15: 401\u2013405.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778\u2013783.","journal-title":"Transplantation"},{"key":"BF1704943_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01704707","volume":"20","author":"GR Bernard","year":"1994","unstructured":"Bernard GR, Artigas A, Brigham KL et al. Report of the American\u2013European consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994; 20: 225\u2013232.","journal-title":"Intensive Care Med"},{"key":"BF1704943_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1158\/1055-9965.EPI-03-0188","volume":"13","author":"AR Kallianpur","year":"2004","unstructured":"Kallianpur AR, Hall LK, Yadav M et al. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol Biomark Prev 2004; 13: 205\u2013212.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"BF1704943_CR41","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1001\/jama.285.17.2216","volume":"285","author":"KK Steinberg","year":"2001","unstructured":"Steinberg KK, Cogswell ME, Chang JC et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. J Am Med Assoc 2001; 285: 2216\u20132222.","journal-title":"J Am Med Assoc"},{"key":"BF1704943_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/sim.4780040112","volume":"4","author":"J Cuzick","year":"1985","unstructured":"Cuzick J . A Wilcoxon-type test for trend. Stat Med 1985; 4: 87\u201390.","journal-title":"Stat Med"},{"key":"BF1704943_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000068487","volume":"109","author":"J Varkonyi","year":"2003","unstructured":"Varkonyi J, Tarkovacs G, Karadi I et al. High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest study on 50 patients. Acta Haematol 2003; 109: 64\u201367.","journal-title":"Acta Haematol"},{"key":"BF1704943_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q","volume":"76","author":"RL Nelson","year":"1995","unstructured":"Nelson RL, Davis FG, Persky V, Becker E . Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995; 76: 875\u2013879.","journal-title":"Cancer"},{"key":"BF1704943_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/10428190290011930","volume":"43","author":"MT Dorak","year":"2002","unstructured":"Dorak MT, Burnett AK, Worwood M . Hemochromatosis gene in leukemia and lymphoma. Leuk Lymphoma 2002; 43: 467\u2013477.","journal-title":"Leuk Lymphoma"},{"key":"BF1704943_CR46","first-page":"40N","volume":"87","author":"KH Muench","year":"1989","unstructured":"Muench KH . Hemochromatosis and infection: alcohol and iron, oysters and sepsis. Am J Med 1989; 87: 40N\u201343N.","journal-title":"Am J Med"},{"key":"BF1704943_CR47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1086\/515549","volume":"25","author":"RL Jurado","year":"1997","unstructured":"Jurado RL . Iron, infections and anemia of inflammation. Clin Infect Dis 1997; 25: 888\u2013895.","journal-title":"Clin Infect Dis"},{"key":"BF1704943_CR48","first-page":"509","volume":"4","author":"G Ho Jr","year":"1992","unstructured":"Ho Jr G . Bacterial arthritis. Curr Opin Rheumatol 1992; 4: 509\u2013515.","journal-title":"Curr Opin Rheumatol"},{"key":"BF1704943_CR49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0891-5849(00)00174-X","volume":"28","author":"M D\u00fcrken","year":"2000","unstructured":"D\u00fcrken M, Herrnring C, Finckh B et al. Impaired plasma antioxidative defense and increased non-transferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic Biol Med 2000; 28: 887\u2013894.","journal-title":"Free Radic Biol Med"},{"key":"BF1704943_CR50","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2141.1997.4143221.x","volume":"99","author":"SJ Bradley","year":"1997","unstructured":"Bradley SJ, Gosriwatana I, Srichairatanakool S et al. Non-transferrin-bound iron induced by myeloablative chemotherapy. Br J Haematol 1997; 99: 337\u2013343.","journal-title":"Br J Haematol"},{"key":"BF1704943_CR51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1440-1746.1999.01828.x","volume":"14","author":"GJ Anderson","year":"1999","unstructured":"Anderson GJ . Non-transferrin-bound iron and cellular toxicity. J Gastroenterol Hepatol 1999; 14: 126\u2013132.","journal-title":"J Gastroenterol Hepatol"},{"key":"BF1704943_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1020707811707","volume":"16","author":"LA Videla","year":"2003","unstructured":"Videla LA, Fernandez V, Tapia G, Varela P . Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals 2003; 16: 103\u2013111.","journal-title":"Biometals"},{"key":"BF1704943_CR53","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/00007890-199212000-00038","volume":"54","author":"CA Foerder","year":"1992","unstructured":"Foerder CA, Tobin AA, McDonald GB, Zager RA . Bleomycin-detectable iron in plasma of bone marrow transplant patients \u2013 its correlation with liver injury. Transplantation 1992; 54: 1120\u20131123.","journal-title":"Transplantation"},{"key":"BF1704943_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/A:1009293500209","volume":"13","author":"ED Weinberg","year":"2000","unstructured":"Weinberg ED . Microbial pathogens with impaired ability to acquire host iron. Biometals 2000; 13: 85\u201389.","journal-title":"Biometals"},{"key":"BF1704943_CR55","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1182\/blood-2002-08-2459","volume":"101","author":"S Ludwiczek","year":"2003","unstructured":"Ludwiczek S, Aigner E, Theurl I, Weiss G . Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003; 101: 4148\u20134154.","journal-title":"Blood"},{"key":"BF1704943_CR56","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1182\/blood.V91.7.2565","volume":"91","author":"S Recalcati","year":"1998","unstructured":"Recalcati S, Pometta R, Levi S et al. Response of monocyte ironregulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood 1998; 91: 2565\u20132572.","journal-title":"Blood"},{"key":"BF1704943_CR57","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood.V96.3.1125","volume":"96","author":"G Montosi","year":"2000","unstructured":"Montosi G, Paglia P, Garuti C et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 2000; 96: 1125\u20131129.","journal-title":"Blood"},{"key":"BF1704943_CR58","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1667\/0033-7587(2000)153[0844:HHMCAR]2.0.CO;2","volume":"153","author":"RG Stevens","year":"2000","unstructured":"Stevens RG, Morris JE, Anderson LE . Commentary: Hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation. Radiat Res 2000; 153: 844\u2013847.","journal-title":"Radiat Res"},{"key":"BF1704943_CR59","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/(SICI)1096-8652(199908)61:4<262::AID-AJH7>3.0.CO;2-B","volume":"61","author":"SM Lichtman","year":"1999","unstructured":"Lichtman SM, Attivissimo L, Goldman IS et al. Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies. Am J Hematol 1999; 61: 262\u2013264.","journal-title":"Am J Hematol"},{"key":"BF1704943_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00007890-199607150-00012","volume":"62","author":"N Azar","year":"1996","unstructured":"Azar N, Valla D, Abdel-Samad I et al. Liver dysfunction in allogeneic bone marrow transplantation recipients. Transplantation 1996; 62: 56\u201361.","journal-title":"Transplantation"},{"key":"BF1704943_CR61","first-page":"685","volume":"4","author":"JR Wingard","year":"1989","unstructured":"Wingard JR, Mellits ED, Jones RJ et al. Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients. Bone Marrow Transplant 1989; 4: 685\u2013689.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR62","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bmt.1703570","volume":"29","author":"A Altes","year":"2002","unstructured":"Altes A, Remacha AF, Sureda A et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 987\u2013989.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.bmt.1701301","volume":"22","author":"SI Strasser","year":"1998","unstructured":"Strasser SI, Kowdley KV, Sale GE, McDonald GB . Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 1998; 22: 167\u2013173.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR64","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/10245332.1999.11746478","volume":"4","author":"M Morado","year":"2000","unstructured":"Morado M, Ojeda F, Garcia-Bustos J et al. BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective Cohort Study. Hematology 2000; 4: 505\u2013512.","journal-title":"Hematology"},{"key":"BF1704943_CR65","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ymgme.2003.11.014","volume":"81","author":"ML Summar","year":"2004","unstructured":"Summar ML, Hall L, Christman B et al. Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. Mol Genet Metab 2004; 81: S12\u2013S19.","journal-title":"Mol Genet Metab"},{"key":"BF1704943_CR66","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/hep.510290205","volume":"29","author":"D Barisani","year":"1999","unstructured":"Barisani D, Cairo G, Ginelli E et al. Nitric oxide reduces non-transferrin-bound iron transport in HepG2 cells. Hepatology 1999; 29: 464\u2013470.","journal-title":"Hepatology"},{"key":"BF1704943_CR67","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/S0021-9258(19)84958-X","volume":"264","author":"CW Cheung","year":"1989","unstructured":"Cheung CW, Cohen NS, Raijman L . Channeling of urea cycle intermediates in situ in permeabilized hepatocytes. J Biol Chem 1989; 264: 4038\u20134044.","journal-title":"J Biol Chem"},{"key":"BF1704943_CR68","first-page":"63","volume":"17","author":"PJ McKay","year":"1996","unstructured":"McKay PJ, Murphy JA, Cameron S et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 1996; 17: 63\u201366.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704943_CR69","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1600-0609.1995.tb00694.x","volume":"54","author":"F Centis","year":"1995","unstructured":"Centis F, Delfini C, Agostinelli F et al. Correlation between soluble transferrin receptor and serum ferritin levels following transplantation for thalassemia. Eur J Haematol 1995; 54: 329\u2013333.","journal-title":"Eur J Haematol"},{"key":"BF1704943_CR70","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF02982790","volume":"76","author":"Y Kohgo","year":"2002","unstructured":"Kohgo Y, Torimoto Y, Kato J . Transferrin receptor in tissue and serum: updated clinical significance of soluble transferrin receptor. Int J Haematol 2002; 76: 213\u2013218.","journal-title":"Int J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704943","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T23:05:01Z","timestamp":1706137501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,18]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["BF1704943"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704943","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,18]]},"assertion":[{"value":"12 February 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}